Within the pharmaceutical
industry, the oncology market is growing at a rapid pace owing to the rising
incidences of cancer. In 2015, 15.2 Million new cancer cases were registered
across the globe. This number is forecasted to increase to a value of 19.3
Million by 2025. Furthermore, the patent expiry of blockbuster cancer drugs is
another major factor which is propelling the growth of the cancer generics
industry.
View Full Report with TOC @ http://www.radiantinsights.com/research/global-cancer-generics-market-forecast-to-2022
"Global Cancer Generics
Market Forecast to 2022", the global cancer generics market is anticipated
to witness a double digit growth during 2016-2022. This report provides a
detailed analysis of the current and future market scenario of the global
cancer generics market. The report provides insight about the major drivers and
challenges, along with the latest trends and developments impacting the
industry growth. In addition, the report also highlights various opportunities
available for growth of the global cancer generics market.
The global cancer generics market
has been segmented on the basis of mode of administration into oral and
injectables. Injectables are the most widely used type of cancer generics
drugs. The report also highlights the major cancer generic drugs available in
the global market.
Request A Sample Copy of This Report at: http://www.radiantinsights.com/research/global-cancer-generics-market-forecast-to-2022/request-sample
Furthermore, the global cancer
generics market has also been segmented on the basis of the major indications
they are used for. According to the report, breast cancer is expected to
account for the largest share in 2016 due to presence of large number of
generic drugs and rising incidences of this indication.
Based on geography, the report
divides market into North America, Europe, and Asia-Pacific. In 2016, North
America is estimated to account for the largest share. Moreover, the report
also lists down various mergers and acquisitions taking place in the global
generics industry.
The last section of the report
discusses about the prominent players in global cancer generics market. A brief
business overview and financial information about each of these players has
been provided, along with their product portfolios. The recent development of
every player has also been presented in the report. Overall, the research
contains exhaustive information that will help clients in formulating market
strategies and assessing opportunity areas in the global cancer generics
market.
About Radiant Insights,Inc
Radiant Insights is a platform for companies looking to
meet their market research and business intelligence requirements. We assist
and facilitate organizations and individuals procure market research reports,
helping them in the decision making process. We have a comprehensive collection
of reports, covering over 40 key industries and a host of micro markets. In
addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
Media Contact:
Company Name: Radiant
Insights, Inc
Contact Person: Michelle
Thoras
Email:
sales@radiantinsights.com
Phone: (415) 349-0054
Address: 28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Comments
Post a Comment